Načítá se...
OP221. Application of a microfluidics system for evaluating the response of Glioblastoma tissues to radiotherapy and chemotherapy
Cancer is a highly heterogeneous disease characterised by multiple genetic lesions and aberrations. It is becoming increasingly clear that the molecular variations that exist within tumours predict prognosis and response to treatment. One way to overcome this is to optimise treatment(s) pre-clinical...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358564/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now292.020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|